Avenue Therapeutics Inc.
05/06/2024 | Press release | Distributed by Public on 05/06/2024 04:10
Additional Proxy Soliciting Materials - Form DEFA14A
atxi20240501_defa14a.htm
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section14(a)of the
Securities Exchange Act of 1934
(Amendment No.____)
|
Filed by the Registrant. |
☒ |
|
Filed by a Party other than the Registrant |
☐ |
Check the appropriate box:
|
☐ |
Preliminary Proxy Statement |
|
☐ |
Confidential, for Use of the Commission Only (as permitted by Rule14a-6(e)(2)) |
| ☐ |
Definitive Proxy Statement |
| ☒ |
Definitive Additional Materials |
|
☐ |
Soliciting Material under §240.14a-12 |
AVENUE THERAPEUTICS,INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|
☒ |
No fee required |
|
☐ |
Fee paid previously with preliminary materials. |
|
☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11 |